SCHEMBL7777978

SCHEMBL7777978

Cc1ccc(-c2c(-c3ccc(S(N)(=O)=O)cc3)nn(CCCO)c2C(F)(F)F)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 13/20 0.62
PTGS1 P23219 5/20 0.62
CA9 Q16790 7/20 0.47
CA1 P00915 6/20 0.47
CA2 P00918 6/20 0.47
CA12 O43570 4/20 0.47
CA4 P22748 3/20 0.47
PDPK1 O15530 2/20 0.47
PTGES O14684 1/20 0.47
HDAC3 O15379 1/20 0.47
PDE5A O76074 1/20 0.47
ABCB11 O95342 1/20 0.47
MT-CO2 P00403 1/20 0.47
LMNA P02545 1/20 0.47
CA3 P07451 1/20 0.47
CYP3A4 P08684 1/20 0.47
ALOX5 P09917 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7777909 0.91 PTGS2 (0.61) PTGS2PTGS1CA9CA1CA2
SCHEMBL7777899 0.91 PTGS2 (0.73) PTGS2PTGS1CA9CA1CA2
SCHEMBL7777642 0.91 PTGS2 (0.62) PTGS2PTGS1CYP2C9
SCHEMBL7777546 0.90 PTGS2 (0.60) PTGS2PTGS1CA9CA1CA2
SCHEMBL7777567 0.90 PTGS2 (0.60) PTGS2PTGS1CA9CA1CA2
SCHEMBL7780762 0.90 PTGS2 (0.60) PTGS2PTGS1CA9CA1CA2
SCHEMBL7779588 0.89 PTGS2 (0.59) PTGS2PTGS1CA9CA1CA2
SCHEMBL7777897 0.89 PTGS2 (0.59) PTGS2PTGS1CA2PDPK1
SCHEMBL7777890 0.87 PTGS2 (0.57) PTGS2PTGS1CA9CA1CA2
SCHEMBL7779248 0.86 PTGS2 (0.53) PTGS2PTGS1CA9CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed